Novelix Pharmaceuticals Ltd

📈 Mallela Venkataramna Reddy Boosts Stake in Novelix Pharmaceuticals

- Mallela Venkataramna Reddy acquired 330,000 equity shares via preferential allotment on February 12, 2026.

- Post-acquisition, his total holding stands at 1,830,000 shares, representing 9.18% of voting rights and 6.71% of diluted voting capital.

- Reddy is classified as a non-promoter shareholder.

- Novelix's equity share capital increased from approximately ₹176.15 million to ₹199.35 million post-allotment, with diluted capital at ₹266.85 million including outstanding warrants.